J&J exec says biotechs aren’t ‘necessarily on sale’ even after a challenging 2021
January 27, 2022 at 09:50 AM EST
The comments made by a Johnson & Johnson executive earlier this week about biotechnology valuations calls attention to the struggling biotech sector.
